AP NEWS

2019 Growth Factors (Blood & Tissue) - Worldwide Market Analysis & Forecast (2016-2024) with 101 Key & Niche Player Profiles - ResearchAndMarkets.com

January 16, 2019

DUBLIN--(BUSINESS WIRE)--Jan 16, 2019--The “Growth Factors (Blood and Tissue) - Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Growth Factors (Blood and Tissue) in US$ Million by the following growth factor Types: Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins), and Tissue Growth Factors.

The report profiles 101 companies including many key and niche players such as:

Amgen, Inc. Bayer HealthCare Pharmaceuticals, Inc. Biocon Ltd. Biogen, Inc. BioMimetic Therapeutics LLC Biopharm GmbH Bolder BioTechnology, Inc. F. Hoffmann-La Roche AG Chugai Pharmaceutical Co. Ltd. Genentech, Inc. FibroGen, Inc. Johnson & Johnson Janssen Biotech, Inc. Lonza Group Merck Serono PeproTech, Inc. Reliance GeneMedix Plc Sangamo Therapeutics, Inc. Sanofi Scil Proteins GmbH Teva Pharmaceutical Industries Ltd. Wockhardt Ltd.

Topics Covered

1. Market Overview

Burgeoning Global Population Offers Significant Growth Opportunities Aging Global Population: Need for New Effective Drugs Increasing Healthcare Spending in Emerging Markets: Opportunities in Store Biologics: Rapidly Gaining Ground Erythropoietin (EPO) Market: An Insight Anemia in CKD and Cancer Patients: Opportunity for EPO Therapy Expanding Pool of ESRD and CKD Patients Triggers Sustained Opportunities Rising Tide of Lifestyle Diseases The Grim Reality Fueling Growth in Renal Diseases Comparison of Erythropoietin-Based Drugs in the US and European Union Safety & Efficacy Issues Concerning ESAs Serum Half-Life: A Key Attribute Differentiating ESAs Patent Expiries of Major Interferon Drugs Colony Stimulating Factors (CSFs) Market in Myeloma Patients Interferon-based Drugs for HCV Treatment: An Insight Patent Expiries Fuel Competition and Sales

2. Growth Factors

3. Product Innovations/Approvals/Introductions

4. Recent Industry Activity

5. Focus on Select Players

6. Global Market Perspective

Total Companies Profiled: 101 (including Divisions/Subsidiaries 116)

The United States (32) Canada (1) Japan (9) Europe (35) France (2)Germany (14)The United Kingdom (5)Rest of Europe (14) Asia-Pacific (Excluding Japan) (36) Middle East (2) Latin America (1)

For more information about this report visit https://www.researchandmarkets.com/research/lrtqzf/2019_growth?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190116005401/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biomaterials

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/16/2019 07:28 AM/DISC: 01/16/2019 07:28 AM

http://www.businesswire.com/news/home/20190116005401/en

AP RADIO
Update hourly